Please provide your email address to receive an email when new articles are posted on . The FDA approved aficamten to improve functional capacity and symptoms in adults with obstructive hypertrophic ...

The ODYSSEY-HCM trial found that mavacamten did not significantly improve exercise capacity or patient-reported outcomes in individuals with symptomatic nonobstructive hypertrophic cardiomyopathy.

The Office of Personnel Management and the Office of Management and Budget have launched a modernization initiative aimed at consolidating more than 100 outdated federal human resources systems into a ...

Hypertrophic cardiomyopathy (HCM) is the most frequently diagnosed cardiac condition in cats, affecting approximately 1 in 7 felines (14%), a rate significantly higher than that seen in humans (1 in ...

Pure, homemade extracts are easy to make and add better flavor to your cooking and baking. These simple instructions can be used to make any extract flavor using quality ingredients—no fillers, ...

The Office of Personnel Management has launched an effort to consolidate the 119 separate human capital management systems in use across various agencies with a single, governmentwide platform that ...

CHARLOTTE, N.C. & STAMFORD, Conn.--(BUSINESS WIRE)--HCM II Acquisition Corp. (Nasdaq: HOND) (“HCM II”), a special-purpose acquisition company and Terrestrial ...

Work described in this story was made possible in part by federal funding supported by taxpayers. At Harvard Medical School, the future of efforts like this — done in service to humanity — now hangs ...